Pablo Cano
Impact in
- Pharmacology top 5%
- Alkaloids: synthesis and pharmacology
- Berberine and alkaloids research
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Oncology 4
- Pancreatic and Hepatic Oncology Research 2
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- John T. Arnason (3 shared papers)Robert M. Lafrenie (2 shared papers)Colin Germond (3 shared papers)Yoo‐Joung Ko (2 shared papers)Scot Dowden (2 shared papers)John A. Stewart (2 shared papers)Sukhbinder Dhesy‐Thind (2 shared papers)Malcolm J. Moore (2 shared papers)
- Journals
- Journal of Ethnopharmacology (3 papers)Journal of Clinical Oncology (3 papers)European Journal of Medicinal Chemistry (1 paper)Liver Cancer (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- CanadaUnited StatesPeru
In The Last Decade
Pablo Cano
12 papers receiving 556 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 130
- Oncology 268
- Cancer Research 118
- Biochemistry 52
- Pharmacology 59
Countries citing papers authored by Pablo Cano
This map shows the geographic impact of Pablo Cano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Cano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Cano more than expected).
Fields of papers citing papers by Pablo Cano
This network shows the impact of papers produced by Pablo Cano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Cano. The network helps show where Pablo Cano may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Cano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 193 | |
| 2 | 2006 | 95 | |
| 3 | 1999 | 76 | |
| 4 | 2009 | 57 | |
| 5 | 2006 | 51 | |
| 6 | 2014 | 40 | |
| 7 | 2009 | 29 | |
| 8 | 1998 | 19 | |
| 9 | 2013 | 13 | |
| 10 | 2017 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2004 | 1 |
About Pablo Cano
Pablo Cano is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 577 indexed citations. Recurring topics across this work include Alkaloids: synthesis and pharmacology (4 papers), Cancer Genomics and Diagnostics (3 papers), Traditional and Medicinal Uses of Annonaceae (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Renal cell carcinoma treatment (2 papers), Cancer Treatment and Pharmacology (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Pharmacology (130 citations), Oncology (268 citations), Cancer Research (118 citations), Biochemistry (52 citations) and Pharmacology (59 citations). Pablo Cano has collaborated with scholars based in Canada, United States and Peru. Frequent co-authors include John T. Arnason, Robert M. Lafrenie, Colin Germond, Yoo‐Joung Ko, Scot Dowden, John A. Stewart, Sukhbinder Dhesy‐Thind, Malcolm J. Moore, Paweł Zalewski and Muhammad Zulfiqar. Their work appears in journals such as Journal of Ethnopharmacology, Journal of Clinical Oncology, European Journal of Medicinal Chemistry, Liver Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.